References
- Abildgaard U., Fagerhol M. K., Egeberg O. Comparison of progressive amithrombin activity and the concentrations of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest 1970; 26: 349
- Bloom A. L., Beck P., Giddings J. C., Sweetnam P. M. Coagulation studies in haemophilic patients taking oral contraceptives. J Clin Path 1971; 24: 23
- Bolton C. H., Hamton J. R., Mitchell J. R. A. Effect of oral contraceptive agents on platelets and plasma-phospholipids. Lancet 1968; 1: 1336
- Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh (Stuttg.) 1965; 13: 516
- Fagerhol M. K., Abildgaard U. Immunological studies on antithrombin III. Scand J Haemat 1970; 7: 10
- Fagerhol M. K., Abildgaard U., Bergsjø P., Jacobsen J. H. Oral contraceptives and low antithrombin III concentration. Lancet 1970; 11: 1175
- Frederiksen H., Ravenholt R. T. Thromboembolism, oral contraceptives and cigarettes. Publ Health Rep 1970; 85: 197
- Howie P. W., Mallinson A. C., Prentice C. R. M., McNicol G. P. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet 1970; 11: 1329
- Hedlin A. M., Monkhouse F. C. Changes in spontaneous fibrinolytic activity during use of oral contraceptives. Obstet Gynec (NY) 1971; 37: 225
- Inman W. H. W., Vcssey M. P. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of childbearing age. Brit Med J 1968; 11: 94
- Larsson-Cohn U. The serum alanine aminotransferase activity and the two-hour sulphobromophlhalein retention test during daily low-dose gestagen oral contraceptive treatment. Acta Soc Med Upsal 1969; 74: 283
- Larsson-Cohn U., Tengstrom B., Wide L. Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment. Acta Endocr (Kbh.) 1969; 62: 242
- Larsson-Cohn U. Contraceptive treatment with low doses of gestagens. Clinical experience with daily oral administration of 0.5 mg of Chlormadinone acetate and 0.5, 0.4 and 0.3 mg of Norethindrone. Acta Endocr (Kbh.) 1970, Suppl. 144
- Larsson-Cohn U., Berlin R., Vikrot O. Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids. Acta Endocr (Kbh.) 1970; 63: 717
- Mancini C., Carbonara O. A., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 1965; 2: 235
- Martinez-Manautou J., Cortez V., Giner J., Aznar R., Casasola J., Rudel H. Low doses of progestogen as an approach to fertility control. Fertil Steril 1966; 17: 49
- Nilsson I. M., Kullander S., Astedt B. Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocr (Kbh.) 1970; 65: 111
- Poller L., Thomson J. M., Tabiowo A., Priest C. M. Progesterone oral contraception and blood coagulation. Brit Med J 1969; 1: 554